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Background: Serum amyloid A (SAA) is useful as a diagnostic marker of systemic inflammation in horses, but only
heterologous assays based on non-equine calibration and standardization are available for measurements of equine
SAA. More accurate measurements could be obtained using purified species-specific SAA in native conformation for
assay calibration and standardization. Further knowledge about the biochemical properties of SAA would facilitate a
future production of native species-specific calibration material Therefore, the aim of the study was an investigation
of the solubility and potentials for purification of equine SAA based on biochemical properties.
Freeze dried equine acute phase serum was dissolved in 70% 2-propanol, 8 M urea, and milli-Q water, respectively.
Supercritical fluid extraction (SFE), size-exclusive chromatography (FPLC-SEC), and preparative isoelectric focusing
(IEF) were performed in the attempt to purify. Immunostaining of IEF blots were used for isoform-specific detection
of SAA in the preparations and purity was assessed by silverstained SDS-PAGE.
Findings: SAA was soluble in 70% 2-propanol, 8 M urea and Milli-Q water. SAA was not separated in the lipophilic
or ampipathic fractions following SFE. SAA was included in a FPLC-SEC-fraction of 237 kDa, despite the molecular
weight known to be much smaller, suggesting binding to other serum constituents. SAA precipitated following
separation of other serum proteins by preparative IEF.
Discussion: No effective purification of SAA was achieved in the present study, but findings important for future
investigations were made. The study suggested that SAA is not exclusively hydrophobic, but appears less
hydrophobic when interacting with other serum components. These results suggest more complex aspects of
solubility than previously believed, and indicate potentials for purification of native SAA.
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Background
The acute phase response is the unspecific reaction to
different stimulations causing systemic inflammation,
like infection or trauma, and is accompanied by marked
increases in the concentrations of major acute phase
proteins [1]. Serum amyloid A (SAA) is a major acute
phase protein in several species of interest in veterinary
medicine [1,2], including horses [3,4], and is a useful
diagnostic marker of inflammation across species [1].* Correspondence: mic@sund.ku.dk
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distribution, and reproduction in any mediumSAA is an apolipoprotein of 10–15 kDa with amphi-
pathic properties and at least three isoforms character-
ized by different isoelectric points have been detected in
equine serum [5,6]. When released into the bloodstream,
it tightly associates with high density lipoproteins (HDL)
[7,8], thus displacing apolipoprotein A1 [9].
Purification of SAA may be of interest for several pur-
poses such as molecular investigations of SAA [10,11],
investigation of the kinetics [5] and functions of SAA
[12], investigation of the pathogenesis of amyloidosis
[13], or production of standards for SAA assays [14].
However, SAA tends to precipitate [13] or form large
protein aggregates [15] when it is separated from HDL,
and consequently, large-scale purification of SAA is a
challenging discipline [16]. Several different protocolsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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several different species, and some protocols have even
been proposed to be useful for large-scale purification
[13]. Ultra-centrifugation is a useful method for separ-
ation of lipoproteins [17], and ultracentrifugation and
hydrophobic interaction chromatography [18] have both
been used as important initial steps in several protocols
for SAA purification, including a protocol for purifica-
tion of equine SAA [5]. When such procedures are
followed by additional purification steps such as gel-
filtering, SAA purities of up to 98% have been demon-
strated [18]. However, the usefulness of the purified
products depends on the aim of the purification. The
antigenic properties of SAA can, thus, be affected by
some purification procedures [14], and immuno-based
SAA assays are, consequently, often based on calibration
and standards consisting of recombinant SAA [19],
heterologous SAA [20], or pooled acute phase serum
[14,21], rather than being based on purified species-
specific SAA. Even though such heterologous calibrated
assays are commercial available for diagnostic measure-
ments of equine SAA [22-24], species-specific calibra-
tion material, consisting of the native purified protein is,
however, needed to obtain precise measurements of
SAA across different analytical methods and different
laboratorial settings [23,25,26]. However, such native pro-
tein material is currently not commercially available [22].
Based on the known biochemical properties of SAA,
size-exclusive chromatography (SEC) and preparative
isoelectric focusing (IEF) have been used as main proce-
dures in previous purifications [5,13,27], but because of
the lipophilic nature of SAA, and the tight association to
HDL, previous purifications have always been preceded by
delipidation steps [5,27,28] like ultracentrifugation [17] or
hydrophobic interaction chromatography (HIC) [18].
A recent report has suggested that porcine SAA has
less lipophilic properties than previously believed [29].
If this is also true for other species, the general ap-
proach to SAA purification should probably be altered
and large scale purification of SAA could maybe be
possible without initial denaturing delipidation or
other steps which could potentially affect the antigenic
properties of the purified product. The use of more
gentle protocols for SAA purification could potentially
facilitate a commercial production of species specific
calibration material for veterinary SAA assays, but
further knowledge about the biochemical properties of
SAA will be needed before such protocols can be
established.
The aim of the study was, therefore, to investigate the
solubility as part of the biochemical properties of equine
SAA and the potentials for purification of SAA using size-
exclusion chromatography (SEC) and preparative isoelectric
focusing (IEF) without initial delipidation.Methods
Pooled equine acute phase serum was used in the study,
based on individual samples from client owned horses
remaining after diagnostic analyses at the Central
Laboratory, Department of Veterinary Clinical and Ani-
mal Sciences, University of Copenhagen, Denmark. The
inclusion of samples in the present study was approved
by the local ethical committee at the Department of
Veterinary Clinical and Animal Sciences, University of
Copenhagen, Denmark. The concentration of SAA in
the serum pool was measured to 1600 mg/L, using a
commercial available turbidimetric immunoassay previ-
ously validated for diagnostic measurements of equine
SAA by members of our group [24]. Fifty millilitres of
the serum pool was freeze dried from –4°C to room
temperature at 10 mbar. An overview of the analytical and
preparative procedures is given in Figure 1. The presence
and composition of SAA was detected in serum and prepa-
rations by IEF, electroblotting (Amersham Pharmacia
Biotech), and immunostaining with anti-SAA antibodies
(Tri-delta Development Ltd), as previously done in several
studies of SAA executed by our group [6,30,31].
Freeze dried serum was suspended in 70% 2-propanol,
8 M urea, and Milli-Q water, respectively, in a concen-
tration of 10 mg freeze dried serum per milliliter solvent.
Supernatants were analyzed for presence of dissolved
SAA isoforms.
Supercritical fluid extraction (SFE) was performed
using 600 mg freeze-dried serum in a Speed SFE system
(Applied Separations). The extraction was performed at
50 mPa with a flow of 4 L CO2 per minute at 40°C for
30 minutes. Extracts were collected in glass vials and the
extraction was repeated using 96% ethanol as modifier
(1.0 mL/min). Extracts and remains were air dried,
diluted in 8 M urea, and analyzed for the presence of
SAA.
SEC was performed by fast polymer liquid chromatog-
raphy (FPLC-SEC) using a Superdex™75 10/300 GL col-
umn (GE Healthcare) and a buffer containing 20 mM
sodium dihydrophosphate and 50 mM sodium chloride,
pH 6.9. A gel filtration standard containing thyroglobu-
lin (660 kDa), gammaglobin (158 kDa), ovalbumin (44
kDa), myoglobin (17 kDa), and cyanocobalamin (1.35
kDa) (Bio-Rad) was used to make a standard curve for
estimating molecular weights of different FPLC-fractions.
Two-hundred microliter of the filtered supernatant
resulting from the suspension of freeze-dried serum in
Milli-Q water (described above) was injected to the
column and separated at a flow of 1 ml/min yelding a
pressure of 1.5 mPa. The molecular weight of equine SAA
was verified by Sodium dodecyl sulphate – polyacrylamide
gel electrophoresis (SDS-PAGE) in Phast Gel System
(Amersham Pharmacia Biotech) followed by electroblotting
and immunostaining as described above. A molecular
Figure 1 Overview of the procedures included in the study. Applied methods (encircled) and obtained products analyzed for SAA content
and impurities (outlined in boxes) in the attempt to purify equine serum amyloid A (SAA). Isoforms of SAA were detected in supernatants,
fractions, and precipitate using isoelectric focusing, electroblotting, and immunostaining. Purity of detected SAA was assessed by sodium dodecyl
sulphate polyacryl amide gel electrophoresis (SDS-PAGE), followed by staining of serum proteins with silver nitrate. SFE: Supercritical fluid
extraction with CO2. FPLC-SEC: Fast polymer liquid chromatography size-exclusive chromatography. IEF: Isoelectric focusing.
Christensen et al. BMC Research Notes 2013, 6:152 Page 3 of 8
http://www.biomedcentral.com/1756-0500/6/152weight marker (Bio Rad) was separated prior to blotting
and stained with silvernitrate (Pharmacia LKB Biotechnol-
ogy) [32] and used as standard.
Preparative IEF was performed in Hoefer IsoPrime IEF
Purification Unit, (Amersham Pharmacia Biotech) [33,34].
Seven buffered polymembranes with pH 5, 6, 7, 7.5, 8, 8.5,
and 9 were prepared with acrylamidobuffers (Fluka
BioChemika and GE Healthcare Biosciences), in gels
consisting of 30% acrylamide/bis-acrylamide (Sigma
Aldrich), Tetramethylethylenediamine (Pharmacia Biothech)
and 40% ammonium persulphate (Bio-Rad). Whatman
glass microfiber filters GF/D 47 mm were encased in the
membranes. Chambers were filled with Milli-Q water
according to recommendations from the manufacturer, and
5 ml of the supernatant resulting from the suspension of
freeze dried serum in 8 M urea (described above) was ap-
plied in separation chamber 2 (between the gels with pH 5
and 6). Separation was performed over 24 hours at a con-
stant power of 4 W. Preparations were air dried and
dissolved in 8 M urea prior to SAA detection. Visible pre-
cipitates were solubilized in 8 M urea overnight at room
temperature, and the solute was investigated for presence
of SAA.
Serum proteins in supernatants, fractions, and precipi-
tate were stained with silvernitrate [32] following SDS-
PAGE in Phast Gel System (Amersham Pharmacia
Biotech) to assess purity of preparations, and a molecu-
lar weight marker was used as standard (Bio Rad).Results
Equine SAA was detected in supernatants of freeze dried
serum solubilized in 70% 2-propanol, 8 M urea, and Milli-
Q water. At least 3 isoforms of SAA were detected in each
solvent, but the isoform pattern in serum dissolved in 8 M
urea resembled the pattern of isoforms detected in un-
treated equine serum most accurately (Figure 2).
Three fractions were obtained by SFE (Figure 1); a
lipophilic fraction (extracted in pure CO2), a lipophilic/
ampophilic fraction (extracted in CO2 modified with
ethanol), and a non SFE-extractable fraction (remains).
SAA was only detectable in the non SFE-extractable
fraction (Figure 3).
Forty-two fractions were obtained by FPLC-SEC of
freeze dried serum diluted in Milli-Q water (Figure 1).
SAA was detected in fraction 9 of the SEC (Figure 4),
corresponding to an estimated molecular weight of 237
kDa, even though the molecular weight of SAA in
equine serum was confirmed to be 10–15 kDa through
SDS-PAGE (Figure 5). The isoform pattern of SAA in
the FPLC-SEC-fraction (Figure 4) seemed to be incom-
plete compared to the material injected to the column
(the supernatant obtained by the suspension of freeze-
dried serum in Milli-Q water, Figure 2, lane 3), and
several other proteins were detected in the SDS-PAGE
analysis of the fraction, showing impurity of the sepa-
rated SAA (Figure 4). No SAA was observed in the
remaining 41 FPLC fractions.
Figure 2 Solubility of serum amyloid A. Detection of serum
amyloid A (SAA) isoforms (by isoelectric focusing and
immunostaining) (A) and assessment of presence of non-SAA
impurities in each of the dissolutions analyzed in A (by sodium
dodecyl sulphate polyacryl amide gel electrophoresis and
silverstaining) (B) following dissolution of freeze-dried equine acute
phase serum in 70% 2-propanol (lane 1), 8 M urea (lane 2), and Milli-
Q water (lane 3). SAA isoform pattern (A) and protein content (B) in
untreated equine serum is seen in lane 4. The molecular weights
(MW) of the BioRad standard are given to the right (S). SAA isoforms
were detected in all solutes (A), but the most preserved isoform
pattern of SAA was observed after dissolution of freeze dried serum
in 8 M urea (lane 2).
Figure 3 No extraction of serum amyloid A by supercritical
fluid extraction. Serum amyloid A (SAA) detected by
immunostaining after isoelectric focusing of fractions obtained after
supercritical fluid extraction (SFE) of freeze dried equine acute phase
serum. SAA was detected in the non-SFE-extractable fraction (lane 1),
while no SAA was detected in the ampophilic/lipophilic (lane 2, extracts
in CO2 modified by 96% ethanol, 1.0 mL/min) and the lipophilic fractions
(lane 3, extracts in pure CO2).
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(Figure 6A), even though protein migration was docu-
mented, especially of serum proteins with acidic isoelec-
tric properties (Figure 6B). SAA was detected in a
precipitate of several serum proteins formed on the gel
surface facing chamber 2, in which sample material was
applied (Figure 6).Discussion
Equine SAA seemed to have more hydrophilic properties
than previously believed, and even though effective puri-
fication of SAA could not be achieved with the methods
used in the present study, the results increase the know-
ledge about the biochemical properties and potentials
for purification of equine SAA. Thus, the present results
Figure 4 Size exclusion chromatography of equine serum
amyloid A. Detection of serum amyloid A (SAA) isoforms and
assessment of purity of SAA separated by size exclusion
chromatography of freeze-dried equine acute phase serum dissolved
in Milli-Q water. A: Immunostained isoforms of SAA after isoelectric
focusing of size exclusion chromatography fractions 9–11. Note the
incomplete isoform pattern compared to the SAA detected in
freeze-dried serum dissolved in Milli-Q water (M, Figure 2A, lane 3),
and note the detection of SAA in fraction 9, corresponding to a
molecular weight of 237 kDa. No SAA was detected in the other 41
fractions. B: Silverstained gel following sodium dodecyl sulphate
polyacryl amide gel electrophoresis (SDS-PAGE) for the assessment
of presence of non-SAA impurities in the fraction analyzed in A.
The molecular weights (MW) of the BioRad standard (S) are given
to the left.
Figure 5 Molecular weight of equine serum amyloid A. Serum
amyloid A (SAA) detected by immunostaining, following sodium
dodecyl sulphate polyacryl amide gel electrophoresis (SDS-PAGE). As
expected, the molecular weight of SAA was estimated to be 10–15
kDa. The molecular weights (MW) of the BioRad standard are given
to the right (S). The standard lane was separated prior to blotting
and stained with silver nitrate.
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Figure 6 Preparative isoelectric focusing of equine serum amyloid A. Detection of serum amyloid A (SAA) isoforms and assessment of purity
of SAA separated by preparative isoelectric focusing (IEF) of freeze-dried equine acute phase serum dissolved in 8 M urea. A: Immunostained
isoforms of SAA after isoelectric focusing of concentrated preparative IEF fractions with pH of <5, 5–6, 6–7, 7–7.5, 7.5-8, 8–8.5, 8.5-9, >9. A visible
precipitate was seen in the application chamber (pI 5–6) after the preparative isoelectric focusing, and was subsequently dissolved in 8 M urea.
Note that SAA was only detected in this precipitate (P). B: Silverstained gel following sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) of equine serum proteins separated in 7 of the pI-intervals by preparative isoelectric focusing. Molecular weights (MW) of the Bio-Rad
standard (S) are given to the right. Note that several serum proteins were detected in the precipitate described above (P).
Christensen et al. BMC Research Notes 2013, 6:152 Page 6 of 8
http://www.biomedcentral.com/1756-0500/6/152could be of importance in the development of protocols
for production of species-specific material for calibration
of diagnostic SAA assays, thus facilitating precise mea-
surements of species-specific SAA.
Solubility of SAA in urea and various buffers
containing phosphate or TRIS has previously been dem-
onstrated [35], but to the author’s knowledge, this is the
first report suggesting solubility of SAA in water, thus
suggesting more hydrophilic properties of equine SAA
than previously reported [5], similar to recent findings in
pigs [29]. The solvents were chosen to facilitate isolation
of SAA from other serum components based on theamphipathic properties of SAA: 2-propanol was chosen
to dissolve SAA and other lipophilic substances, without
dissolving hydrophilic serum components, Milli-Q-water
was chosen to dissolve hydrophilic substances, without
dissolving SAA and other lipophilic serum components,
and 8M urea was chosen because of its chaothrophic
properties and because it has been a useful media for
analytical procedures of SAA detection [6,30,31]. Conse-
quently, the dissolution of SAA in 70% 2-propanol and 8
M urea was expected. More isoforms and more intense
bands of SAA were detected in 8 M urea, suggesting
both quantitative and qualitative better solubility in this
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quantify the solubility and to investigate the maximal
solubility in different solvents. The detection of SAA in
freeze dried serum dissolved in Milli-Q water, however,
suggests more hydrophilic properties than previously be-
lieved, or suggests interactions between SAA and other
serum substances with more hydrophilic properties.
Hydrophilic properties of SAA or SAA complexes, could
also explain the failure to extract SAA by SFE, as lipo-
philic and ampophilic/lipophilic substances are expected
to be extractable by this procedure, as previously ob-
served for different drugs [36]. Additional studies are
needed to investigate whether the biochemical properties
of equine SAA is of similar nature as the recently ob-
served properties demonstrated in pigs [29], but unlike
in porcine SAA purification [29], HIC has previously
been shown to be useful as an initial step for purification
of equine SAA [5]. Thus, hydrophilic properties of SAA
complexes seem to be a more probable explanation of
the results than hydrophilic properties of the SAA mol-
ecule itself. Further, SAA precipitated during preparative
IEF, when other serum components were separated.
Other serum components seem, consequently, to be ne-
cessary in order to keep SAA solubilized under hydro-
philic conditions, as also suggested previously [13].
Higher concentrations of urea would probably facilitate
the separation of SAA isoforms by preparative IEF [35],
thus avoiding the observed precipitation. However, the
conditions used in the present study could potentially be
useful as an early purification step separating proteins
with acidic pI values. Such substances could for instance
be albumin (pI 4.6-4.7 [37]), which has been shown to
be one of the potential contaminants during SAA purifi-
cations [11].
Aggregation of lipoproteins with other serum proteins
is commonly observed [15], and was further confirmed
by the results of the FPLC-SEC, since SAA was sepa-
rated with a higher apparent molecular weight than
expected. The isoform pattern obtained by detection of
SAA in the FPLC-SEC fraction was, however, incomplete
and as the lacking isoforms were not detected in other
fractions either, precipitation in the column, as observed
after preparative IEF, or a partly binding to the column
during the chromatography could not be ruled out. Re-
peated gel filtering has previously been used for puri-
fication of equine SAA [5,38], but because of many
impurities observed in this and other studies [14], and
because of the apparent loss of SAA isoforms during the
FPLC-SEC in the present study this method seems to be
less useful for purifications aiming to obtain calibration
material.
In conclusion, our study indicated unexpected hydro-
philic properties of equine SAA, as SAA could be
detected following dissolution of lyophilized acute phaseserum in Milli-Q water and as SAA was not extracted
by SFE. Further studies are, however, needed to explore
the nature of possible interactions with other serum
components increasing the hydrophilic properties of
SAA, and the significance of these unexpected biochem-
ical properties. Our attempt to purify equine SAA was
unsuccessful, but the results, however, contribute to the
knowledge about the biochemical properties of SAA,
and can consequently be of importance in future studies
of SAA’s properties and purification.
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